Literature DB >> 11372754

Immunoglobulin variable region structure and B-cell malignancies.

H Kiyoi1, T Naoe.   

Abstract

The enormous diversity of immunoglobulin (Ig) variable (V) gene sequences encoding the antibody repertoire are formed by the somatic recombination of relatively few genetic elements. In B-lineage malignancies, Ig gene rearrangements have been widely used for determining clonality and cell origin. The recent development of rapid cloning and sequencing techniques has resulted in a substantial accumulation of IgV region sequences at various stages of B-cell development and has revealed stage-specific trends in the use of V, diversity, joining genes, the degree of noncoding nucleotide addition, and the rate of somatic mutations. Furthermore, sequences from B-lineage malignant cells nearly reflect the characteristics of the normal counterpart at each respective stage of development. Alternatively, from the IgV region structure of the malignant cells, it is possible to speculate at which stage of B-cell development the cells were transformed. As the complete nucleotide sequences of the human Ig heavy and Ig light V region loci have now been determined, the study of Ig genetics has entered into the super-information era.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372754     DOI: 10.1007/BF02981902

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  81 in total

Review 1.  Molecular analysis of immunoglobulin genes in multiple myeloma.

Authors:  C Kosmas; K Stamatopoulos; N Stavroyianni; C Belessi; N Viniou; X Yataganas
Journal:  Leuk Lymphoma       Date:  1999-04

Review 2.  Regulation of human B-cell ontogeny.

Authors:  F M Uckun
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

3.  Comparison of the immunoglobulin gene transcripts between immature B lineage acute lymphoblastic leukemia and the normal phenotypic counterparts in the bone marrow.

Authors:  H Mori; H Kiyoi; K Horibe; R Ohno; T Naoe
Journal:  Leukemia       Date:  1997-08       Impact factor: 11.528

4.  Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  A Bräuninger; M L Hansmann; J G Strickler; R Dummer; G Burg; K Rajewsky; R Küppers
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

5.  The pattern of joining (JH) gene usage in the human IgH chain is established predominantly at the B precursor cell stage.

Authors:  R Wasserman; Y Ito; N Galili; M Yamada; B A Reichard; S Shane; B Lange; G Rovera
Journal:  J Immunol       Date:  1992-07-15       Impact factor: 5.422

6.  Detection of monoclonal B lymphocytes in bone marrow and peripheral blood of multiple myeloma patients by immunoglobulin gene rearrangement studies.

Authors:  I Van Riet; C Heirman; P Lacor; M De Waele; K Thielemans; B Van Camp
Journal:  Br J Haematol       Date:  1989-11       Impact factor: 6.998

7.  Myelomonocytic antigen positive multiple myeloma.

Authors:  T M Grogan; B G Durie; C M Spier; L Richter; E Vela
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

Review 8.  Differential usage of an autoantibody-associated VH gene, VH4-21, by human B-cell tumors.

Authors:  F K Stevenson; M B Spellerberg; C J Chapman; T J Hamblin
Journal:  Leuk Lymphoma       Date:  1995-02

9.  Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearrangement in trans.

Authors:  S Takeda; Y R Zou; H Bluethmann; D Kitamura; U Muller; K Rajewsky
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

10.  The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus.

Authors:  F Matsuda; K Ishii; P Bourvagnet; K i Kuma; H Hayashida; T Miyata; T Honjo
Journal:  J Exp Med       Date:  1998-12-07       Impact factor: 14.307

View more
  3 in total

1.  Epigenetic regulation of CD20 protein expression in a novel B-cell lymphoma cell line, RRBL1, established from a patient treated repeatedly with rituximab-containing chemotherapy.

Authors:  Akihiro Tomita; Junji Hiraga; Hitoshi Kiyoi; Manabu Ninomiya; Takumi Sugimoto; Masafumi Ito; Tomohiro Kinoshita; Tomoki Naoe
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

2.  Detection of monoclonal immunoglobulin heavy chain gene rearrangement (FR3) in Thai malignant lymphoma by High Resolution Melting curve analysis.

Authors:  Tanawan Kummalue; Anchalee Chuphrom; Sanya Sukpanichanant; Tawatchai Pongpruttipan; Sathien Sukpanichanant
Journal:  Diagn Pathol       Date:  2010-05-19       Impact factor: 2.644

3.  Detailed characterization of the transcriptome of single B cells in mantle cell lymphoma suggesting a potential use for SOX4.

Authors:  Simone Valentin Hansen; Marcus Høy Hansen; Oriane Cédile; Michael Boe Møller; Jacob Haaber; Niels Abildgaard; Charlotte Guldborg Nyvold
Journal:  Sci Rep       Date:  2021-09-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.